WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+12.81%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.5B
Cap. Flow
% of AUM
13.19%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| 1 |
Microsoft
MSFT
|
$247M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$152M |
| 3 |
Brown & Brown
BRO
|
$120M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
$113M |
| 5 |
Akero Therapeutics
AKRO
|
$106M |
Top Sells
| 1 |
Lam Research
LRCX
|
$144M |
| 2 |
MetLife
MET
|
$97.2M |
| 3 |
Travelers Companies
TRV
|
$91.9M |
| 4 |
Electronic Arts
EA
|
$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
$80.3M |
Sector Composition
| 1 | Healthcare | 25.08% |
| 2 | Technology | 24.07% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Capital One
COF
$142B
| $14.7M | 0.08% |
69,187
+36,982
| +115% | +$7.87M |
|
352
Pebblebrook Hotel Trust
PEB
$1.4B
| $14.7M | 0.08% |
1,468,035
-1,508,772
| -51% | -$15.1M |
|
353
MoonLake Immunotherapeutics
MLTX
$3.77B
| $14.7M | 0.08% |
310,602
+14,454
| +5% | +$682K |
|
354
Celanese
CE
$5.34B
| $14.6M | 0.08% |
+263,047
| New | +$14.6M |
|
355
Birkenstock
BIRK
$9.23B
| $14.4M | 0.08% |
292,831
-90,739
| -24% | -$4.46M |
|
356
Edgewise Therapeutics
EWTX
$1.64B
| $14.4M | 0.08% |
1,096,863
+54
| +0% | +$708 |
|
357
Comcast
CMCSA
$125B
| $14.4M | 0.08% |
402,854
-1,502,543
| -79% | -$53.6M |
|
358
UnitedHealth
UNH
$286B
| $14.3M | 0.08% |
45,869
-31,882
| -41% | -$9.95M |
|
359
T-Mobile US
TMUS
$284B
| $14M | 0.07% |
+58,695
| New | +$14M |
|
360
Deere & Co
DE
$128B
| $13.9M | 0.07% |
27,304
+5,905
| +28% | +$3M |
|
361
CrowdStrike
CRWD
$105B
| $13.7M | 0.07% |
26,942
-59,576
| -69% | -$30.3M |
|
|
HES
362
DELISTED
Hess
HES
| $13.7M | 0.07% |
98,990
-126,860
| -56% | -$17.6M |
|
363
Amicus Therapeutics
FOLD
$2.46B
| $13.7M | 0.07% |
2,386,446
+2,085,616
| +693% | +$12M |
|
364
Intel
INTC
$107B
| $13.7M | 0.07% |
610,037
+4,293
| +0.7% | +$96.2K |
|
365
Maximus
MMS
$4.97B
| $13.7M | 0.07% |
+194,499
| New | +$13.7M |
|
366
Teladoc Health
TDOC
$1.38B
| $13.6M | 0.07% |
+1,560,442
| New | +$13.6M |
|
|
LINE
367
Lineage, Inc. Common Stock
LINE
$9.29B
| $13.6M | 0.07% |
312,299
+272
| +0.1% | +$11.8K |
|
368
Lowe's Companies
LOW
$151B
| $13.4M | 0.07% |
60,542
+12,838
| +27% | +$2.85M |
|
369
Qualcomm
QCOM
$172B
| $13.4M | 0.07% |
84,185
+8,589
| +11% | +$1.37M |
|
370
Visteon
VC
$3.41B
| $13.3M | 0.07% |
+142,367
| New | +$13.3M |
|
371
Nokia
NOK
$24.5B
| $13.2M | 0.07% |
+2,554,141
| New | +$13.2M |
|
372
Dynatrace
DT
$15.1B
| $13.1M | 0.07% |
+237,999
| New | +$13.1M |
|
373
Beam Therapeutics
BEAM
$2.11B
| $13M | 0.07% |
761,498
+887
| +0.1% | +$15.1K |
|
374
Linde
LIN
$220B
| $12.9M | 0.07% |
27,475
-12,753
| -32% | -$5.98M |
|
375
Sociedad Química y Minera de Chile
SQM
$13.1B
| $12.6M | 0.07% |
358,117
+328,446
| +1,107% | +$11.6M |
|